Journal of Vaccines & Vaccination

4^th International Conference on Vaccines & Vaccination

September 24-26, 2014 Valencia Convention Centre, Spain

Accepted Abstracts

• Potency determination of the 3rd national standard of Japanese encephalitis virus vaccine for in vivo & in vitro assay

  Mi Sook Yang, Hyung-sil Moon, Do Keun Kim, Hae Joo Jung, Naery Lee, Donghee Kim, Seokkee Chang, Jiyoung Hong and Ho Jung Oh

  PDF HTML

• Establishing a HIV vaccine research unit from scratch: The Walter Sisulu University experience

  Jimmy Chandia

  PDF HTML

• Evaluation of a 3A-truncated foot-and-mouth disease virus in pig for its potential as marker vaccine

  Pinghua Li, Hong Yin and Zaixin Liu

  PDF HTML

• Study on the preparation and anti-tumor biological effects of gastric cancer cell-dendritic cell fusion vaccine

  Kun Zhang

  PDF HTML

• A novel cell clone adapted to serum-free medium, qb-tn9-cl-f, which overproduces baculovirusintroduced recombinant proteins derived from new Trichoplusia ni cell line

  Guoxun Li, Guo We, Shiying Zhang, Robert R Granados and Shan Ming

  PDF HTML

• A multivalent chimeric vaccine to Schistosoma mansoni composed of recombinant Sm29 and Sm- TSP-2 was able to induce an additive protective effect against challenge infection in mice

  Carina S Pinheiro, Ana Paula Dias Ribeiro, Fernanda C Cardoso, Vicente P Martins, Barbara C P Figueiredo, Natan R G Assis, Suellen B Morais, Marcelo V Caliari, Alex Loukas and Sergio C Oliveira

  PDF HTML

• Increased frequency of activated cytotoxic T-lymphocytes in HIV infected patients facilitate HIV associated dementia

  Gurleen and Sunil K Arora

  PDF HTML

• MHC binding peptide prediction models: New approach for vaccine development

  Virendra Gomase

  PDF HTML

• Mice orally immunized with a transgenic plant expressing the glycoprotein of crimean-congo hemorrhagic fever virus

  Sadegh Chinikar, Seyed Mojtaba Ghiasi, Nariman Shah-Hosseini, Sahar Khakifirouz and Tahmineh Jalali

  PDF HTML

• Evaluation of HPV16 L1-L2 fusion protein expression in mammalian cells

  Ali Namvar, Azam Bolhassani, Mehrdad Hashemi and Elnaz Agi

  PDF HTML

• Influence of long-term exposure of obesity induced by unsaturated high-fat diet on the cardiac remodeling process

  Mumuni Abdul Malik

  PDF HTML

• A potent candidate black water fever malaria vaccine in the offing, Ugandan case

  Akusa Darlington and Ondoa Christine

  PDF HTML

• Assay of IL-22/IL-25 in serum, whole blood and peripheral blood mononuclear cell cultures of patients with severe asthma

  Alireza Zamani, Ebrahim Nadi, Mehdi Arjipour and Shirin Sharifi

  PDF HTML

• Expanded program of immunization coverage and associated factors among children age 12-23 months in Arba Minch town and Zuria district, Southern Ethiopia, 2013

  Worku Animaw, Wondimagegn Taye, Behailu Merdekios, Marilign Tilahun and Gistane Ayele

  PDF HTML

• Evaluation of aspergillosis serology patients in high risque area of chu d?oran

  Zakaria Benmansour

  PDF HTML

• Influence of natural and synthetic immunomodulators on the effectiveness of vaccines in fish

  Siwicki Andrzej Krzysztof

  PDF HTML

• Identification of highly immunogenic and protective Leishmania major antigen that elicits strong T cell recall responses in recovered human patients

  Jude E Uzonna

  PDF HTML

• Mucosal vaccine delivery system based on lactic acid bacteria (LAB)

  Jagusztyn-Krynicka Elzbieta Katarzyna, Kobierecka Patrycja and Wyszyńska Agnieszka

  PDF HTML

• Evaluation of the efficacy, safety and immunity of chitosan-based oral fowl typhoid vaccine

  Onuigbo Ebele, Attama Anthony, Chah Kennedy, Gyang Moses and Okore Vincent

  PDF HTML

• Insights of vaccine production challenges in developing countries: Current status in Tanzania

  Zachariah E Makondo, Stella Bitanyi, Andrew Chota and Richard Mwakapuja

  PDF HTML

• A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis

  Ana Paula Junqueira-Kipnis, Adeliane C da Costa, Abadio O C Junior, Fabio M Oliveira, Sarah V Nogueira, Joseane D Rosa, Danilo P Resende and Andre Kipnis

  PDF HTML

• Therapeutic vaccination for the control of Johne?s disease using native strain of Mycobacterium avium subspecies paratuberculosis in animals: Can it be a model for the control of TB and leprosy in human beings and animal

  Shoor Vir Singh

  PDF HTML

• Comparison and immunogenic evaluation of thermostable NDV I-2 and LaSota vaccines against Newcastle disease virus in Pakistan

  Faisal Siddique, Muhammad Shahid Mahmood, Iftikhar Hussain, Azhar Rafique, Syied I Ahmad, Asif Iqbal and Farrah Deeba

  PDF HTML

• Synthetic enhanced EP delivered Ig plasmid vector drives biologically relevant anti-HIV-1 envelope responses in vivo

  Kar Muthumani, Seleeke Flingai, Megan Wise, Colleen Tingey, Kenneth Ugen and David B Weiner

  PDF HTML

• Characterization of different antigens in Salmonella abortusovis for developing a vaccine

  Daniela Chessa

  PDF HTML

• P16 Immunostaining and HPV testing in histological specimens from uterine cervix

  Pier Luigi Cherchi and Giampiero Capobianco

  PDF HTML

• Structurally-modulated antigens as anti-malarial vaccine components

  Jose Manuel Lozano Moreno

  PDF HTML

• Susceptibility of human antigen-specific CD4 T cells to HIV: Implications for HIV vaccine response

  Haitao Hu

  PDF HTML

• The pancreas and human immunodeficiency virus

  Ethel Zimberg Chehter

  PDF HTML

• Devices and rationale for intradermal injection of vaccines

  Zach Marks

  PDF HTML

• Towards a vaccine for human rhinoviruses

  Gary R McLean

  PDF HTML

• Loxosceles spider bites envenomation immunotherapy

  Liza Felicori

  PDF HTML

• Circulating level of interleukin (IL)-18 in Helicobacter pylori-infected patients, and its associations with bacterial CagA and VacA virulence factors

  Ebrahim Eskandari-Nasab

  PDF HTML

• A clinical trial to evaluate the safety and immunogenicity of a novel DNA vaccine used in combination with meglumine antimoniate as immunotherapy during leishmaniasis

  Laura Manna

  PDF HTML

• HIV-1 diversity and challenges toward development of effective vaccines

  Elichilia Shao

  PDF HTML

• Lessons learned from the Uganda immunization training program

  Nicholas Ayebazibwe, Sheba Gitta and Fred Wabwire-Mangen

  PDF HTML

• Comparison of potency and immunogenicity of ERA and PV virus strain based cell culture antirabies vaccine produced in Ethiopia

  Abebe Mengesha, Birhanu Hurisa, Amdemicael Adhanom, Gezhagn Kebede, Dereje Nigussie, Hailu Lemma, Gashawu Gebrewold, and Kelbessa Urga

  PDF HTML

• Development and evaluation of Staphylococcus epidermidis DNA, mRNA and protein vaccines

  Lin Yan

  PDF HTML

• Presentation of an immunodominant epitope in a given protein antigen is not always intrinsic: Implication in peptide vaccine design

  Syamal Roy

  PDF HTML

• Reversal of poor peptide-MHC II stability in Leishmania donovani infection by liposomal cholesterol: Implication in therapy

  Syamal Roy

  PDF HTML

• Africa and the global HIV vaccine research agenda: Opportunities and challenges

  Chidi Victor Nweneka

  PDF HTML

• HCV therapeutic vaccines: Generation of infectious HCV-3a pseudo-particles containing functional E1-E2 envelope protein complexes

  Muhammad Idrees and Shazia Rafique

  PDF HTML

• Type 1 diabetes oral vaccine based on SPI2-T3SS of live attenuated Salmonella

  Mohamed I Husseiny Elsayed

  PDF HTML

• APC-targeting increases immunogenicity of DNA vaccines, and can modulate the type of immune responses that are induced

  Gunnveig Grodeland, Siri Mjaaland, Agnete Brunsvik Fredriksen and Bjarne Bogen

  PDF HTML

• Vaccine coverage in elderly is related to lower mortality for respiratory diseases

  Angelo Jose Goncalves Bos

  PDF HTML

• DNA Vaccine that target hemagglutinin to MHC II-molecules rapidly induces antibody-mediated protection against influenza

  Bjarne Bogen

  PDF HTML

• Nasal vaccine as a tool for conferring rapid-sustained-broad protection against pathogens without inducing systemic inflammation

  De-chu Christopher Tang

  PDF HTML

• Research and development of biodefence vaccines

  E D Williamson

  PDF HTML

• Tumour associated antigens which act as biomarkers of survival and targets for immunotherapy in acute myeloid leukaemia

  Barbara Guinn

  PDF HTML

• Defeating meningococcal disease: From a glycoconjugate vaccine against MenACWY to a proteinbased vaccine against meningococcus B

  Vega Masignani

  PDF HTML

• Induction of de novo HCV core-specific cell-;mediated immune responses and enhancement of neutralizing antibodies response by CIGB-230, a DNA-based vaccine candidate, on triple therapy with IFN-α plus ribavirin

  Amador-Canizares Y, Martinez-Donato G, Alvarez-Lajonchere L, Vasallo C, Dausa M, Aguilar-Noriega D, Valenzuela C, Raices I, Dubuisson J, Wychowski C, Cinza-Estevez Z, Castellanos M, Nunez M4, Armas A, Gonzalez Y J, Reve I, Guerra I1, Perez-Aguiar A and Duenas-Carrera S

  PDF HTML

• Development of novel therapeutic hepatitis B vaccine

  Gerardo Guillen

  PDF HTML

• The significance of VBNC in the biopharmaceutical industry: A new challenge for small local producers

  Vesna Kovacevic-Jovanovic

  PDF HTML

• Role of PPAR receptors in both atopic dermatitis and psoriasis

  Amira Tawdy

  PDF HTML

• How to foster innovation to meet the global gap of novel vaccines: Learnings from the European Institute of Innovation and Technology, EIT

  Alexander von Gabain

  PDF HTML

• Knowledge, attitudes and acceptability of human papilloma vaccination among primary school girls in Minakulu sub-county Northern Uganda

  Vian Namanya Katagwa

  PDF HTML